NSCLC With M7824 Second Line Therapy
Byoung Chul Cho, M.D., Yonsei Cancer Center discusses NSCLC With M7824 Second Line Therapy. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
Author: Cancer-News
Added: 10/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 29, 2018 Category: Cancer & Oncology Source Type: podcasts
What To Expect In NSCLC & HN Cancer For 2019
Byoung Chul Cho, M.D., Yonsei Cancer Center discusses What To Expect In NSCLC & HN Cancer For 2019. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
Author: Cancer-News
Added: 10/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Gastric & Esophageal Cancer: Treating Female Patients
Michael Davidson, M.D., Royal Marsden Hospital, discusses Gastric & Esophageal Cancer: Treating Female Patients. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
Author: Cancer-News
Added: 10/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Gender Differences: Gastric & Esophageal Cancer Treatment
Michael Davidson, M.D., Royal Marsden Hospital, discusses Gender Differences: Gastric & Esophageal Cancer Treatment. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
Author: Cancer-News
Added: 10/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Larotrectinib, Xofigo, Copanlisib, & Regorafenib Research
Scott Fields, SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Larotrectinib, Xofigo, Copanlisib, & Regorafenib Research. At ESMO Oncology Conference - Munich, Germany O...
Author: Cancer-News
Added: 10/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Treatment With Xofigo, Abiraterone, & Copanlisib
Scott Fields, SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Treatment With Xofigo, Abiraterone, & Copanlisib. At ESMO Oncology Conference - Munich, Germany On October...
Author: Cancer-News
Added: 10/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Using Mutational Signatures To Tailor New Treatments
Thomas Helleday, Phd, Helleday Laboratory, Discusses Using Mutational Signatures To Tailor New Treatments. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
Author: Cancer-News
Added: 10/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 29, 2018 Category: Cancer & Oncology Source Type: podcasts
SL-701 Phase Two Trial Study Results
David Peereboom, MD, Cleveland Clinic Discusses SL-701 Phase Two Trial Study Results. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
Author: kidneycancer
Added: 10/26/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 26, 2018 Category: Cancer & Oncology Source Type: podcasts
Radiological Phenotyping For Glioma Study Outcomes
Diana Roettger, PhD, Head of Scientific and Medical Affairs and Imaging Clinical Research Expert at AIG Discusses Radiological Phenotyping For Glioma Study Outcomes. At ESMO Oncology Conference - Muni...
Author: kidneycancer
Added: 10/26/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 26, 2018 Category: Cancer & Oncology Source Type: podcasts
Next Steps In Image Analysis Research
Diana Roettger, PhD, Head of Scientific and Medical Affairs and Imaging Clinical Research Expert at AIG Discusses Next Steps In Image Analysis Research. At ESMO Oncology Conference - Munich, Germany O...
Author: kidneycancer
Added: 10/26/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 26, 2018 Category: Cancer & Oncology Source Type: podcasts
Machine Learning & AI Contributions To Research
Diana Roettger, PhD, Head of Scientific and Medical Affairs and Imaging Clinical Research Expert at AIG Discusses Machine Learning & AI Contributions To Research. At ESMO Oncology Conference - Munich,...
Author: kidneycancer
Added: 10/26/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 26, 2018 Category: Cancer & Oncology Source Type: podcasts
Advanced Imaging & AI In Clinical Trials
Diana Roettger, PhD, Head of Scientific and Medical Affairs and Imaging Clinical Research Expert at AIG Discusses Advanced Imaging & AI In Clinical Trials. At ESMO Oncology Conference - Munich, German...
Author: kidneycancer
Added: 10/26/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 26, 2018 Category: Cancer & Oncology Source Type: podcasts
Progress In Advanced Kidney Cancer Treatment
Robert Motzer MD, board-certified medical oncologist of Memorial Sloan Kettering Cancer Center, discusses Progress In Advanced Kidney Cancer Treatment At ESMO Oncology Conference - Munich, Germany On ...
Author: kidneycancer
Added: 10/26/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 26, 2018 Category: Cancer & Oncology Source Type: podcasts
Differences Between NSCLC & SCLC
Pascal Besman Chief Operating Officer at PharmaMar Discusses Differences Between NSCLC & SCLC. At ESMO Oncology Conference - Munich, Germany On October 19, 2018
Author: kidneycancer
Added: 10/26/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 26, 2018 Category: Cancer & Oncology Source Type: podcasts
Optimal Approach To Small Renal Mass
Brian Shuch, MD Associate Professor of Urology at UCLA Discusses the Optimal Approach To Small Renal Mass. At Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL on Septe...
Author: kidneycancer
Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts
